Biopol Global Co., Ltd

Dear Sir or Madam,

We are pleased to have a chance to introduce ourselves.
We are one of the leading manufacturers in the field of advanced wound dressings named MEDIFOAM (Hydrophilic Polyurethane Foam Dressing) and have supplied the products to Netherland, Saudi Arabia, Malaysia, Vietnam since 2002 and have plan to export to Japan and U.S.A in exclusive base from 2004.
We have been also supplying the products to major hospitals, pharmacies with good
reputation in Korea and it's market share is more than 70%.
It is clinically proven that MEDIFOAM protects the wound surface from bacterial invasion
maintaining optimal moisture wound environment and absorbs the exudates very effectively.
It's major advantages comparing to traditional wound dressing such as gauzes is as follows:

- It is comprised of a highly effective, super
  absorbent polyurethane foam and thin,
  waterproof, semi-permeable PU film.
- It decreases scar formation
- It reduces the pain when changing the dressing
  because it is not adhesive to the wound
  surface.
- It provides a moist wound environment.
- It protects against contaminants.

We got the international certifications such as ISO9001, EN46001, and U.S FDA approval.
We recommend you visit our homepage for more product information.
If you have any question regarding products,  pls do not hesitate to contact us any time.

Look forward to hearing from you soon.   Thank you.

Best regards,

H.S. Yoon / Global Marketing Manager


- Corporate Overview -

Web: www.biopolglobal.com
     www.biopol.co.kr
     www.medifoam.co.kr

Established: Aug 29, 2000
Capital: U$1.4 Milllion
Capacity: 100 Million pieces per year
Primary shareholders:
1) ILDONG Pharmaceutical Co., Ltd
2) Korea Development Bank
3) SK Chemical
4) HYUNDAI Investment & Securities Co., Ltd